Physician profile
Hui Du
NPI 1083636419
$1,902.36
in general payments reported to CMS, 2019-2025
11 companies · $652 in 2025
The $652 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $69.65 · 2023: $308 · 2024: $745 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $540.33 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $386.28 | 2023-2025 | Simbrinza, Rocklatan, Rhopressa |
| Sun Pharmaceutical Industries INC. | $255.62 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $237.47 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Harrow Eye, LLC | $208.37 | 2024-2025 | Vevye |
| Allergan, INC. | $90.13 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $66.96 | 2024-2025 | Xdemvy |
| Amgen INC. | $57.44 | 2024 | Tepezza |
| Thea Pharma INC. | $21.00 | 2024 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $19.78 | 2021 | |
| Merz North America, INC. | $18.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hui Du listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.